Lisa Barrett

Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics

A. Osinusi, Eric G. Meissner, Y.-J. Lee et al. · JAMA · 2013 · 285 citations · Full text

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

Darrell H. S. Tan, Mark Hull, Deborah Yoong et al. · Canadian Medical Association Journal · 2017 · 221 citations · Full text

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Anita Kohli, A. Osinusi, Zayani Sims et al. · The Lancet · 2015 · 151 citations

Hepatology, Hepatitis C, Week Triple-drug Regimens +9

Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study

Alison D. Marshall, Sahar Saeed, Lisa Barrett et al. · CMAJ Open · 2016 · 85 citations · Full text

Investigating the Sensitivity of Nasal or Throat Swabs: Combination of Both Swabs Increases the Sensitivity of SARS-CoV-2 Rapid Antigen Tests

Barbara Goodall, Jason J. LeBlanc, Todd F. Hatchette et al. · Microbiology Spectrum · 2022 · 37 citations · Full text